[1]
“Formulation and Characterization of Imatinib Mesylate Liposomes in Gel for Intraarticular administration”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 5, pp. 559–566, Sep. 2022, doi: 10.25004/IJPSDR.2022.140508.